Clinical Trials Logo

Clinical Trial Summary

Non functioning pituitary adenomas (NFPAs) are the most common pituitary adenomas. Their growth is usually slow and diagnosis is often made in the context of masse effect .The therapeutic alternatives are surgery and radiotherapy such as fractionated stereotactic radiotherapy. Nowadays, there is no clinical or histological prognostic factor to allow an individualized follow-up and recurrence could happen 10 or 15 years after the first surgery. In this study, the investigators evaluate NFPAs recurrence rate after surgery and try to find predictive factors of recurrence to personalized the follow-up of each patient.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02803697
Study type Observational
Source CHU de Reims
Contact
Status Completed
Phase
Start date November 2015
Completion date December 31, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT01442220 - Genome-wide Association Study of Pituitary Tumors N/A
Recruiting NCT01377701 - The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor N/A
Completed NCT00939523 - Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy Phase 2
Not yet recruiting NCT04244708 - The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas Phase 2/Phase 3